Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 11, 2012 - Issue 4
Submit an article Journal homepage
338
Views
7
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

Safety and efficacy of pharmacological cardioversion of atrial fibrillation using intravenous vernakalant, a new antiarrhythmic drug with atrial selectivity

Carina Blomström-LundqvistUppsala University, Department of Cardiology, Department of Medical Sciences, S-75185 Uppsala, Sweden+46 18 611 3113; +46 18 51 02 43; [email protected]
, MD PhD &
Per BlomströmUppsala University, Department of Cardiology, Department of Medical Sciences, S 75185 Uppsala, Sweden
, MD PhD
Pages 671-679 | Published online: 26 May 2012

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yukiomi Tsuji & Dobromir Dobrev. (2013) Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update. Vascular Health and Risk Management 9, pages 165-175.
Read now

Articles from other publishers (6)

Sudarone Thihalolipavan & Daniel P. Morin. (2015) Atrial Fibrillation and Heart Failure: Update 2015. Progress in Cardiovascular Diseases 58:2, pages 126-135.
Crossref
Mohamed Zeriouh, Anton Sabashnikov, Yeong-Hoon Choi, Javid Fatullayev, Hannes Reuter, Aron-Frederik Popov, Georg Langebartels, Lucas Kimmig, Parwis B Rahmanian, Thorsten Wittwer, Klaus Neef, Jens Wippermann & Thorsten Wahlers. (2014) A novel treatment strategy of new onset atrial fibrillation after cardiac surgery: an observational prospective study. Journal of Cardiothoracic Surgery 9:1.
Crossref
Sudarone Thihalolipavan & Daniel P. Morin. (2014) Atrial Fibrillation and Congestive Heart Failure. Heart Failure Clinics 10:2, pages 305-318.
Crossref
Alina Scridon & Dan Dobreanu. 2014. Atrial Fibrillation Therapy. Atrial Fibrillation Therapy 23 54 .
Joseph J. LynchJrJr, Christopher P. Regan, Gregory N. Beatch, Gilbert W. Gleim & Christopher J. Morabito. (2013) Comparison of the Intrinsic Vasorelaxant and Inotropic Effects of the Antiarrhythmic Agents Vernakalant and Flecainide in Human Isolated Vascular and Cardiac Tissues. Journal of Cardiovascular Pharmacology 61:3, pages 226-232.
Crossref
Jordi Heijman, Niels Voigt & Dobromir Dobrev. (2013) New directions in antiarrhythmic drug therapy for atrial fibrillation. Future Cardiology 9:1, pages 71-88.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.